Variant report
Variant | nsv970767 |
---|---|
Chromosome Location | chr7:110188474-110189770 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:110182691..110184718-chr7:110187881..110190742,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs374282106 | chr7:110188478-110188479 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs571180677 | chr7:110188503-110188504 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs540162790 | chr7:110188506-110188507 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs115143610 | chr7:110188521-110188522 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs573396082 | chr7:110188531-110188532 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs151084688 | chr7:110188551-110188552 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs141118172 | chr7:110188561-110188562 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs376312186 | chr7:110188562-110188563 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs76464638 | chr7:110188583-110188584 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs544223138 | chr7:110188630-110188631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs554369148 | chr7:110188642-110188643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs191168464 | chr7:110188662-110188663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs10249554 | chr7:110188743-110188744 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs560292116 | chr7:110188783-110188784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs529081578 | chr7:110188785-110188786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs549022350 | chr7:110188819-110188820 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs1911710 | chr7:110188835-110188836 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs114815953 | chr7:110188849-110188850 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs548170322 | chr7:110188869-110188870 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs551373386 | chr7:110188880-110188881 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs571297235 | chr7:110188886-110188887 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs540114683 | chr7:110188896-110188897 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs79433935 | chr7:110188910-110188911 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs111709816 | chr7:110188932-110188933 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs72343009 | chr7:110188933-110188934 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs78408164 | chr7:110188946-110188947 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567005007 | chr7:110188953-110188954 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs535689077 | chr7:110188969-110188970 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs375338112 | chr7:110189034-110189035 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs555415688 | chr7:110189041-110189042 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs10265390 | chr7:110189043-110189044 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs537985251 | chr7:110189048-110189049 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs182502458 | chr7:110189061-110189062 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs577663496 | chr7:110189081-110189082 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs540475330 | chr7:110189097-110189098 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs539960914 | chr7:110189112-110189113 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs73205276 | chr7:110189113-110189114 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs530516226 | chr7:110189130-110189131 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs1911711 | chr7:110189156-110189157 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs570570849 | chr7:110189167-110189168 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542478390 | chr7:110189195-110189196 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs562699742 | chr7:110189200-110189201 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs540836208 | chr7:110189211-110189212 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs531416955 | chr7:110189234-110189235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs113748302 | chr7:110189280-110189281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs559074379 | chr7:110189293-110189294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs192012682 | chr7:110189294-110189295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs527289240 | chr7:110189303-110189304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs184624597 | chr7:110189307-110189308 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs367732254 | chr7:110189317-110189318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Breast cancer | 16397240 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Autism | 19401682 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
small cell lung cancer | 20016488 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:110184400-110188600 | Weak transcription | HMEC | breast |
2 | chr7:110188000-110189000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
3 | chr7:110188000-110189200 | Enhancers | NHEK | skin |
4 | chr7:110188200-110188600 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
5 | chr7:110188200-110188800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
6 | chr7:110188200-110189000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
7 | chr7:110188400-110188800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr7:110188600-110189000 | Enhancers | HMEC | breast |
9 | chr7:110188800-110197000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
10 | chr7:110189000-110194600 | Weak transcription | HMEC | breast |